You are on page 1of 3

Paper Product

20 February 2014 Result Update Q3, FY 14 CMP- Rs. 79

Paper Product (PPL) reported quarterly and CY number. On quarterly basis top line grew by 23% (YoY) while EBIDTA grew by 14% while EBIDTA margin declined by 75bps. On full year basis PPL reported top line growth of 20% (cons.) while EBIDTA margin improved by 100 bps. ~ Standalone entity grew by 12% on full year basis while on quarterly basis standalone entity posted 18.9% (yoy) and 3% (qoq). ~ Gross margin of standalone entity declined to 27% from 31% in Q4,12 hence EBIDTA margin declined only 130 bps due to better product mix and cost efficiency. Volatility in currency is major culprit in fall of GP margin. ~ Management expects that GP margin has bottomed out at current level and expect reach to normal level in coming future. ~ Last year PPL had spent almost Rs. 31 cr. on capital expansion and for CY 14 PPL guided for Rs. 70 crore Capex. However We believe given a economic circumstance company will spent around Rs. 45 crore. ~ Subsidiary is almost 1/10 of size of PPL Standalone entity. We expect this company to grow faster than standalone entity because of low base. ~ Subsidiary posted healthy top line growth mainly because of low base. EBIDTA Margin of subsidiary company is also healthy around For Private Circulation Only

20%. Management also indicated that margin of this company will stabilized around 16% as scale of operation grow. ~ Management guided Rs. 20 cr. capex in CY 14 for this subsidiary. ~ CY 13 company generated healthy CFO of Rs. 51 crore. ~ Company expects despite slow down indias consumption story still intact and expect 5 years CAGR of 12-15%.

Reference Items Gross Margin % EBIDTA Margin % EBIT Margin % EBT Margin % PAT Margin %

Q4,13 29.0% 9.7% 5.9% 5.6% 6.2%

Q4,12 32.0% 10.5% 6.2% 6.0% 4.4%

bps -306 -75 -30 -38 180

Q3,13 30.5% 9.6% 5.7% 5.3% 3.4%

bps -151 8 19 23 276

Anand Rathi Retail Research

Paper Product
20 February 2014 Result Update Q3, FY 14 CMP- Rs. 79

Income Statement (consol) Net Sales Growth % Cost of materail GP Employee Other Expenses EBIDTA Depreciation EBIT Finance Cost EBT Other Income Forex Gain/( loss) Exceptional Gain PBT Tax Net Income

Q4,13 281.47

Q4,12 229.39

Var % 22.7

Q3,13 269.44

Var % 4.5

Financial Estimates (Cons.) Sales EBIDTA

CY 12a 900.6 91.2 10.1% 45.1 7.20

CY 13a 1085.5 116.8 10.8% 56.2 8.98

CY 14e 1222.0 128.7 10.5% 59.1 9.44

CY 15e 1389.5 146.7 10.6% 67.1 10.72

199.98 81.49 18.9 35.19 27.4 10.77 16.63 0.93 15.7 0.77 0.15 7.05 23.37 5.94 17.43

155.96 73.43 18.34 31.03 24.06 9.82 14.24 0.57 13.67 1.72 0.24

28.2 11.0 3.1 13.4 13.9 9.7 16.8 63.2 14.9 -55.2 -37.5

187.36 82.08 22.89 33.19 26 10.6 15.4 0.99 14.41 0.68 1.07

6.7 -0.7 -17.4 6.0 5.4 1.6 8.0 -6.1 9.0 13.2 -86.0

EBIDTA Margin Net Income EPS

Figures are in Rs. Cr. except per share data

~ Valuation: We are revising our target price from Rs. 84.6 to Rs. 95. We expect company will grow at 13% CAGR from CY13-15. Currently stock is quoting at 7.2x and 8.2x PE for CY14e and CY 15e respectively. On EV/EBIDTA front PPL is quoting at 3.7x and 3.3x for CY 14e and CY15e respectively. At our target stock implied PE is 8.9x for CY 15e. Risk: Slowdown in economy will impact consumer expenditure hence volume of the company can be impacted. Currency fluctuation can lead to deterioration of margin.

15.15 5.08 10.07

54.3 16.9 73.1

14.02 4.78 9.24

66.7 24.3 88.6

Figures are in Rs. Cr. except per share data

For Private Circulation Only

Anand Rathi Retail Research

Paper Product
20 February 2014 Result Update Q3, FY 14 CMP- Rs. 79

CA Vivek Gujrati vivekgujrati@rathi.com Tel No: +91 22 4001 3867

Disclaimer This report has been issued by Anand Rathi Share & Stock Brokers Ltd.(ARSSBL ), which is regulated by . This report has been issued by Anand Rathi Share & Stock Brokers Ltd.(ARSSBL ), which is regulated by SEBI. The information herein was obtained from various sources; we do not guarantee its accuracy or completeness. Neither the information nor any opinion expressed constitutes an offer, or an invitation to make an offer, to buy or sell any securities, options, future or other derivatives related to such securities (related investment). ARSSBL and its affiliated may trade for their own accounts as market maker/ jobber and /or arbitrageur in any securities of this issuer(s) or in related investments, and may be on the opposite side of public orders. ARS, its affiliates, directors, officers, and employees may have a long or short position in any securities of this issuer(s) or in related investment banking or other business from, any entity mentioned in this report. This research report is prepared for private circulation. It does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this report. Investors should seek financial situation and the particular needs of any specific investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realized. Investors should note that income from such securities, if any, may fluctuate and that each security's price or value may rise or fall. Past performance is not necessarily a guide to future performance. Foreign currency rates of exchange may adversely affect the value, price or income of any security or related investment mentioned in this report. For Private Circulation Only Anand Rathi Retail Research